News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Maruho, Toray Industries, Inc. To Collaborate In Developing And Marketing Candidate Compound For Atopic Dermatitis Drug


10/19/2005 5:13:11 PM

Tokyo (JCNN) - Maruho and Toray (TSE: 3402) jointly announced that they have concluded an agreement for TRK-820, a drug candidate for treating the itching of atopic dermatitis. Under the terms of the agreement, set out on March 31, the two companies will jointly conduct R&D for TRK-820. Maruho will be in charge of sales.

Read at JCN Newswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES